Niall O'Donnell
CIK 1780235 · last filed 2023-06-08
Niall O'Donnell is a corporate insider who has filed 16 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for MIRM, was dated Sep 6, 2023. Across all open-market trades the lifetime net is +$8.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $155.6M across reported positions. 1 Form 144 notice of planned sales is also on file; the latest, for MIRM on Sep 6, 2023, lists the filer as a director.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MIRM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
101 SOUTH HANLEY RD., STE 1850
ST. LOUIS, MO 63105
Holdings By Company
Holdings By Holder
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-06 | MIRM | Notice (144) Director · Planned Sep 6, 2023 No sale on file |
−51,000 | -$1.43M | EDGAR |
| 2023-06-08 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | SPRB | Grant (A) | — | $0 | EDGAR |
| 2023-05-16 | SPRB | Buy (P) | +630,400 | $2.00M | EDGAR |
| 2023-05-10 | OnKure Therapeutics, Inc. (RPHM) Delisted | Buy (P) | +125,000 | $1.00M | EDGAR |
| 2022-11-15 | MIRM | Sell (S) | −300,000 | -$5.96M | EDGAR |
| 2022-06-06 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | SPRB | Grant (A) | — | $0 | EDGAR |
| 2021-06-08 | MIRM | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).